<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02464995</url>
  </required_header>
  <id_info>
    <org_study_id>5886</org_study_id>
    <nct_id>NCT02464995</nct_id>
  </id_info>
  <brief_title>Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations</brief_title>
  <acronym>THERMASCORT</acronym>
  <official_title>Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the effectiveness of bronchial thermoplasty in a
      severe asthmatic population with frequent exacerbations.

      This will be a single center randomized and controlled study. Thirty subjects with severe
      asthma (Gina 4 and 5) with frequent severe exacerbations (four or more bursts of systemic
      corticosteroids &gt;3 days each in the previous year) will be randomized 1:1 to either the
      thermoplasty group (bronchial thermoplasty and medical management) or control group (medical
      management only).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2015</start_date>
  <completion_date type="Anticipated">November 9, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severe exacerbation rate (change from baseline)</measure>
    <time_frame>Baseline, 6 months and 12 months after the last thermoplasty procedure</time_frame>
    <description>A severe exacerbation is defined by a burst of systemic corticosteroids &gt;3 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to the first severe asthma exacerbation</measure>
    <time_frame>anytime</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean oral glucocorticosteroid dose (mg equivalent prednisone)</measure>
    <time_frame>Baseline, 6 and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mild exacerbation rate</measure>
    <time_frame>Baseline, 6 and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre- and post-bronchodilator FEV1</measure>
    <time_frame>Baseline, 6 and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Questionnaire (ACQ) Score</measure>
    <time_frame>Baseline, 3, 6, 9 and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Quality of Life Questionnaire (AQLQ) Score</measure>
    <time_frame>Baseline, 3, 6, 9 and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural airway remodeling using CT</measure>
    <time_frame>Baseline and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory cells and markers in induced sputum</measure>
    <time_frame>Time Frame: Baseline and 12 Months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Thermoplasty group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure: Bronchial thermoplasty with the Alair System and conventional therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bronchial thermoplasty with the Alair System</intervention_name>
    <arm_group_label>Thermoplasty group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age 18-65 years

          -  Asthma which requires treatment with guidelines suggested medications for GINA steps
             4-5

          -  Four or more bursts of systemic corticosteroids &gt;3 days each in the previous year

          -  Willingness and ability to give written informed consent

        Exclusion criteria:

          -  Current smoker and former smoker &gt; 10 pack years total smoking history

          -  Participation in another clinical trial within the prior 4 months

          -  Omalizumab therapy within the prior 4 months

          -  Allergic bronchopulmonary aspergillosis

          -  Patient having had severe exacerbation of their asthma requiring high doses of oral
             corticosteroids (&gt; 60 mg equivalent prednisolone) more than one month in the previous
             year

          -  Post-bronchodilator FEV1 of less than 30%

          -  Past diagnosis of COPD and chronic respiratory insufficiency

          -  Known coagulopathy or platelet dysfunction

          -  Use of anticoagulants

          -  Use of an internal or external pacemaker or internal cardiac defibrillator

          -  Contraindication to perform bronchoscopy

          -  Contraindication to perform general anesthesia

          -  Significant cardiovascular disease

          -  Current or recent respiratory tract infection resolved less than 4 weeks

          -  Known cancer or cancer history less than 12 months

          -  Pregnancy and nursing mother
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>HÃ´pitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Molard, PhD</last_name>
      <email>anita.molard@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>June 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <last_update_submitted>August 7, 2017</last_update_submitted>
  <last_update_submitted_qc>August 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma,</keyword>
  <keyword>Asthma exacerbation</keyword>
  <keyword>Bronchial thermoplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

